An Open Label, Dose Finding Trial of Viagra for the Treatment of Neuropathic Pain (in Diabetes Mellitus)
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study if sildenafil (Viagra) is effective in improving
neuropathic pain. This will be an open label study at 3 doses of sildenafil (25 mg, 50 mg and
100 mg). If this study suggests efficacy, the information will be used to plan a placebo
controlled, double-blind study in the future.